' ▁activities , ▁and ▁the ▁remaining ▁€ 2 0 0 ▁million ▁from ▁industry , ▁char ities , ▁and ▁private ▁organis ations . ▁The ▁Part ners hip ▁is ▁intended ▁to ▁be ▁a ▁long - term ▁initi ative ▁( 1 0 – 2 0 ▁years ) ▁and ▁a ▁separate ▁legal ▁entity ▁has ▁been ▁created ▁to ▁maintain ▁its ▁independence ▁and ▁flex ibility . ▁ ▁T aken ▁together , ▁clin ical ▁tri als ▁based ▁in ▁developing ▁countries ▁where ▁the ▁dise ases ▁are ▁en demic , ▁capacity ▁building , ▁and ▁South - S outh ▁networking ▁are ▁expected ▁to ▁make ▁up ▁over ▁ 9 0 % ▁of ▁the ▁overall ▁budget . ▁( figure ). ▁ ▁Member ▁states ▁and ▁partners ▁▁▁ ▁Europe ▁ ▁EU ▁member ▁states , ▁plus ▁Norway ▁and ▁Switzerland ▁. ▁▁ ▁Develop ing ▁countries ▁ ▁All ▁sub - S ah aran ▁African ▁countries . ▁▁ ▁Indust ry ▁and ▁commercial ▁ ▁Bayer ▁ ▁Gla x o Smith K line ▁ ▁Nov art is ▁Ph arma ▁ ▁Nov o ▁Nord isk ▁ ▁San of i ▁P aste ur ▁ ▁San of i - A vent is . ▁▁ ▁International ▁initi atives ▁ ▁The ▁World ▁Health ▁Organ ization ▁( W HO - T DR ) ▁( http :// www . who . int / td r /) ▁ ▁Dru gs ▁for ▁Neg lect ed ▁D ise ases ▁initi ative ▁( http :// www . d nd i . org ) ▁ ▁International ▁A ids ▁V acc ine ▁In iti ative ▁( I AV I ) ▁( http :// www . ia